Wang ZB - Search Results

1

STK25: a viable therapeutic target for cancer treatments?

Chen KQ, Lei GL, Ke BY, Chen L, Wang ZB, Wang SZ. Chen KQ, et al. Among authors: wang zb, wang sz. Anticancer Drugs. 2023 Oct 1;34(9):995-1001. doi: 10.1097/CAD.0000000000001490. Epub 2023 Dec 23. Anticancer Drugs. 2023. PMID: 36728989 Review.

2

Apelin-13 inhibits lipoprotein lipase expression via the APJ/PKCα/miR-361-5p signaling pathway in THP-1 macrophage-derived foam cells.

Zhang X, Ye Q, Gong D, Lv Y, Cheng H, Huang C, Chen L, Zhao Z, Li L, Wei X, Zhang M, Xia X, Yu X, Zheng X, Wang S, Wang Z, Tang C. Zhang X, et al. Acta Biochim Biophys Sin (Shanghai). 2017 Jun 1;49(6):530-540. doi: 10.1093/abbs/gmx038. Acta Biochim Biophys Sin (Shanghai). 2017. PMID: 28444107 Free article.

3

Ibrolipim attenuates early-stage nephropathy in diet-induced diabetic minipigs: Focus on oxidative stress and fibrogenesis.

Liu Y, Li H, Wang S, Yin W, Wang Z. Liu Y, et al. Biomed Pharmacother. 2020 Sep;129:110321. doi: 10.1016/j.biopha.2020.110321. Epub 2020 Jun 12. Biomed Pharmacother. 2020. PMID: 32535382 Free article.

4

Microtubule affinity regulating kinase 4: A promising target in the pathogenesis of atherosclerosis.

Qin YS, Li H, Wang SZ, Wang ZB, Tang CK. Qin YS, et al. Among authors: wang zb, wang sz. J Cell Physiol. 2022 Jan;237(1):86-97. doi: 10.1002/jcp.30530. Epub 2021 Jul 21. J Cell Physiol. 2022. PMID: 34289095 Review.

5

Salusins: advance in cardiovascular disease research.

Chen MX, Deng BY, Liu ST, Wang ZB, Wang SZ. Chen MX, et al. Among authors: wang zb, wang sz. J Pharm Pharmacol. 2023 Mar 12;75(3):363-369. doi: 10.1093/jpp/rgac087. J Pharm Pharmacol. 2023. PMID: 36508340 Review.

6

Research and progress of inflammasomes in nonalcoholic fatty liver disease.

Chen KQ, Ke BY, Cheng L, Yu XQ, Wang ZB, Wang SZ. Chen KQ, et al. Among authors: wang zb, wang sz. Int Immunopharmacol. 2023 May;118:110013. doi: 10.1016/j.intimp.2023.110013. Epub 2023 Mar 15. Int Immunopharmacol. 2023. PMID: 36931172 Review.

7

Research and Progress of Probucol in Nonalcoholic Fatty Liver Disease.

Chen KQ, Ke BY, Cheng L, Guan MT, Wang ZB, Wang SZ. Chen KQ, et al. Among authors: wang zb, wang sz. Mini Rev Med Chem. 2023;23(19):1905-1911. doi: 10.2174/1389557523666230324092842. Mini Rev Med Chem. 2023. PMID: 36967462 Review.

8

Progress in Research on CNPY2 in Diseases.

Chen KQ, Zhang YQ, Wang ZB, Wang SZ. Chen KQ, et al. Among authors: wang zb, wang sz. Mini Rev Med Chem. 2024;24(4):391-402. doi: 10.2174/1389557523666230601094149. Mini Rev Med Chem. 2024. PMID: 37259932 Review.

9

Mechanism of efferocytosis in atherosclerosis.

Shu LX, Cao LL, Guo X, Wang ZB, Wang SZ. Shu LX, et al. Among authors: wang zb. J Mol Med (Berl). 2024 May 10. doi: 10.1007/s00109-024-02439-3. Online ahead of print. J Mol Med (Berl). 2024. PMID: 38727748 Review.

10

A minipig model of high-fat/high-sucrose diet-induced diabetes and atherosclerosis.

Xi S, Yin W, Wang Z, Kusunoki M, Lian X, Koike T, Fan J, Zhang Q. Xi S, et al. Int J Exp Pathol. 2004 Oct;85(4):223-31. doi: 10.1111/j.0959-9673.2004.00394.x. Int J Exp Pathol. 2004. PMID: 15312127 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

753 results

Search Page